Active Ingredient: ROLAPITANT HYDROCHLORIDE
Proprietary Name: VARUBI
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N208399
Product Number: 001
Approval Date: Oct 25, 2017
Applicant Holder Full Name: TERSERA THERAPEUTICS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
